COEP
NASDAQ · Biotechnology
Coeptis Therapeutics Holding
$2.79
+0.15 (+5.68%)
Open$2.70
Previous Close$2.64
Day High$2.83
Day Low$2.63
52W High$21.41
52W Low$2.11
Volume—
Avg Volume431.4K
Market Cap102.06M
P/E Ratio—
EPS$-0.88
SectorBiotechnology
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.06M | 8.74M | 7.84M |
| Net Income | -17,995,573 | -2,031,310 | -1,359,886 |
| Profit Margin | -874.3% | -23.2% | -17.3% |
| EBITDA | -18,585,812 | -2,389,064 | -2,398,436 |
| Free Cash Flow | — | -1,186,852 | -1,098,506 |
| Rev Growth | — | +14.6% | -0.2% |
| Debt/Equity | 0.02 | 0.28 | 0.25 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $266.28 | +0.73% | 74.3 | 468.50B |
| AMGN | Amgen Inc | $418.13 | +0.85% | 25.1 | 219.78B |
| GILD | Gilead Sciences Inc | $152.21 | +0.85% | — | 185.02B |
| VRTX | Vertex Pharmaceuticals Inc | $527.67 | +0.28% | 30.5 | 134.17B |
| REGN | Regeneron Pharmaceuticals | $752.25 | -4.54% | 18.8 | 81.31B |
| ALNY | Alnylam Pharmaceuticals Inc | $255.36 | -0.23% | 41.4 | 33.44B |